An estimated 300 million people worldwide suffer fromchronic hepatitis C with a prevalence of 0.8%-1.0% of the general p......

目的：探讨聚乙二醇干扰素联合利巴韦林治疗不同基因型慢性丙型肝炎（丙肝）的疗效。方法：80例丙肝患者,采用特异性探针杂交法进行丙肝病......